Dare Bioscience, Inc. (DARE)

NASDAQ: DARE · IEX Real-Time Price · USD
1.19
-0.03 (-2.46%)
Aug 17, 2022 4:00 PM EDT - Market closed

Ratios and Metrics (Quarterly)

Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Quarter Ended Current2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-30
Market Capitalization
10110412515311893805132262114131416811131013191324192958747710012618412585117
Enterprise Value
707387102738573472722171011912121-66106122052732213755142773157
PE Ratio
--3.45-3.14-3.96-3.13-2.87-2.62-1.86-1.38-1.41-1.29-0.91-0.92-1.07-1.32-0.48-0.48-0.61-0.51-1.14-7.33-13.44-2.08-28.88-0.82-1.27-1.66-1.93-2.75-4.00-6.36-5.36-4.39-6.87
PS Ratio
10.0910.42----------------------------5563.261564.72987.521357.13
PB Ratio
3.063.154.053.953.6912.0424.54-44.20-22.7484.636.5331.037.192.794.231.211.161.090.610.980.843.183.05-27.341.732.252.061.571.701.844.542.761.622.02
Debt / Equity Ratio
0.040.040.040.010.010.060.18-0.66-0.623.080.211.82---0.00--------0.980.890.650.520.420.250.210.360.070.080.08
Current Ratio
3.033.032.923.453.032.341.570.910.881.281.981.151.723.324.196.648.4510.1319.748.6412.372.432.340.062.473.383.994.737.4611.1011.086.569.3610.97
Buyback Yield / Dilution
-69.26%-69.26%-88.63%-72.90%-124.06%-88.83%-86.99%-66.74%-89.34%-65.85%-108.36%-57.90%-46.06%-41.00%-31.52%-253.61%-129.07%-1155.18%-854.35%-280.97%-500.38%66.75%66.74%69.00%69.59%-2.52%-34.46%-88.11%-35.69%-58.09%-2485.87%-1761.42%-2668.20%-2646.84%
Total Shareholder Return
-69.26%-69.26%-88.63%-72.90%-124.06%-88.83%-86.99%-66.74%-89.34%-65.85%-108.36%-57.90%-46.06%-41.00%-31.52%-253.61%-129.07%-1155.18%-854.35%-280.97%-500.38%66.75%66.74%69.00%69.59%-2.52%-34.46%-88.11%-35.69%-58.09%-2485.87%-1761.42%-2668.20%-2646.84%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).